Objectives: To determine the frequency of hypothyroidism in patients with viralhepatitis receiving interferon treatment. Study Design: Descriptive cross sectional. Setting:Department of Medicine, Jinnah Postgraduate Medical Centre, Karachi. Duration of Study: Sixmonths. Subjects and Methods: All patients with age 30 to 60 years of either gender havingpersistent or intermittent elevation of alanine arninotransferase (ALT, the upper limit of normalALT is 40 IU/L) over a six-month period and Anti-HCV positivity and detection of HCV-RNA inthe sera On IFN-α mono therapy for more than 3 months were enrolled. History of duration ofdisease and treatment was obtained from patients. A 3 cc blood sample of Patients were drawnand send for TSH level. Presence of TSH level >4.0 miU/L was labelled as Hypothyroidism.Results: Mean age of the patients was 51.79±7.96 years. There were 51 (43.60%) males and 66(56.40%) females. Mean TSH level was 3.98±0.23 mIU/L. Mean duration of HCV was 6.42±1.67months. Mean duration of treatment was 5.42±1.67 months. Frequency of hypothyroidism wasfound in 62 (53%) patients. Conclusion: The frequency of hypothyroidism in patients with viralhepatitis receiving interferon treatment was found to be 62 (53%).
ABSTRACT… Objectives:To determine the frequency of hypothyroidism in patients with viral hepatitis receiving interferon treatment. Study Design: Descriptive cross sectional. Setting: Department of Medicine, Jinnah Postgraduate Medical Centre, Karachi. Duration of Study: Six months. Subjects and Methods: All patients with age 30 to 60 years of either gender having persistent or intermittent elevation of alanine arninotransferase (ALT, the upper limit of normal ALT is 40 IU/L) over a six-month period and Anti-HCV positivity and detection of HCV-RNA in the sera On IFN-α mono therapy for more than 3 months were enrolled. History of duration of disease and treatment was obtained from patients. A 3 cc blood sample of Patients were drawn and send for TSH level. Presence of TSH level >4.0 miU/L was labelled as Hypothyroidism. Results: Mean age of the patients was 51.79±7.96 years. There were 51 (43.60%) males and 66 (56.40%) females. Mean TSH level was 3.98±0.23 mIU/L. Mean duration of HCV was 6.42±1.67 months. Mean duration of treatment was 5.42±1.67 months. Frequency of hypothyroidism was found in 62 (53%) patients. Conclusion: The frequency of hypothyroidism in patients with viral hepatitis receiving interferon treatment was found to be 62 (53%).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.